
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.(MIST)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mist · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$8.00
Consensus
$7.33
+495.9% upside
Low
$6.00
Median: $8 · Last Close: $1.23
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$7.33
495.9% upside
High Target
$8
550.4%
Low Target
$6
387.8%
Current Price
$1.23
as of today
Based on analyst price targets, the MIST stock price prediction for the next 12 months ranges from $6 to $8. The consensus MIST price forecast of $7.33 implies 495.9% upside from the current price of $1.23.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.17 | ↓ 5.00% |
1-day model range: $1.16–$1.18. Peak: $1.18 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $2 | +50.0% |
| 2028 | $2 | +87.5% |
| 2029 | $3 | +110.9% |
| 2030 | $3 | +124.1% |
| 2031 | — | +131.1% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MIST · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-14 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-01-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-16 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-12-15 | TD Cowen | Upgrade ↑ | Hold→Buy |
| 2025-12-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Milestone Pharmaceuticals Inc. (MIST) stock. Of the recent 36 rating actions, 4 were upgrades and 4 were downgrades. 7 analysts currently cover MIST.
分析师推荐趋势
MIST analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$7M
↓ 94.7% YoY
Revenue Next Year
$29M
↑ 315.1% YoY
EPS This Year
$-0.93
EPS Next Year
$-1.02
↑ 9.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast MIST EPS of $-0.93 for the current fiscal year, based on estimates from 4 analysts. The MIST revenue forecast is $7M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MIST 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MIST 的共识目标价为 $7.33(+495.9% 上行空间),分析师共识为 Buy。
MIST 的短期预测(明日)为 $1.17(-5.00%)。 MIST 对 2027 年的股价预测均值为 $2。 MIST 对 2030 年的预测区间为 $3–$3。
Milestone Pharmaceuticals Inc. 在 NASDAQ 上市,代码 MIST。MIST 在 2027 年的整体展望偏积极,在覆盖分析师中约 86% 对应 Buy 共识。
常见问题
MIST 预测 · 8 个问题根据 7 位华尔街分析师,MIST 的 12 个月平均目标价为 $7.33,最高 $8.00、最低 $6.00。若有图表,中位目标价可在上方查看。相对当前价 $1.23,隐含约 +495.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.